Skip to main content
Vicky Makker, MD, Oncology, New York, NY, Memorial Sloan Kettering Cancer Center

VickyMakkerMD

Oncology New York, NY

Instructor, Medicine, Weill Cornell Medical College

Overview of Dr. Makker

Dr. Vicky Makker is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from University of Florida College of Medicine and has been in practice 14 years. Dr. Makker accepts several types of health insurance, listed below. She is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. She has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2003 - 2006
  • University of Florida College of Medicine
    University of Florida College of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • NY State Medical License
    NY State Medical License 2006 - 2025
  • NJ State Medical License
    NJ State Medical License 2019 - 2025

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Case Report Next-Generation Sequencing Based Detection of Germline and Somatic Alterations in a Patient with Four Metachronous Primary Tumors  
    Joshua K Sabari, Gulisa Turashvili, Vicky Makker, Darragh F Halpenny, ScienceDirect

Lectures

  • A phase 3 trial evaluating efficacy and safety of lenvatinib in combination with pembrolizumab in patients with advanced endometrial cancer. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Lenvatinib + pembrolizumab in patients with advanced endometrial cancer: Updated results. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Implementing a Burnout Prevention Program Among Medical Oncology Fellows: Challenges, Successes, and Opportunities 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
  • Join now to see all

Press Mentions

  • For Advanced Endometrial Cancer, Chemotherapy plus Immunotherapy Improves Outcomes
    For Advanced Endometrial Cancer, Chemotherapy plus Immunotherapy Improves OutcomesMarch 28th, 2023
  • Gynecologic Cancer Clinicians and Researchers Recognized at SGO 2022 Annual Meeting on Women’s Cancer
    Gynecologic Cancer Clinicians and Researchers Recognized at SGO 2022 Annual Meeting on Women’s CancerMarch 21st, 2022
  • ENGOT and the GOG Foundation, Inc. (GOG) Announce Promising First Results of New Maintenance Therapy for Advanced or Recurrent Endometrial Cancer
    ENGOT and the GOG Foundation, Inc. (GOG) Announce Promising First Results of New Maintenance Therapy for Advanced or Recurrent Endometrial CancerMarch 17th, 2022
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Minnesota Blue Cross Accord
    BCBS Tennessee Network 5
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment